ClinicalTrials.gg
Status unknownNCT05484479Updated Dec 23, 2022

Effect of Baduanjin Exercise on Chronic Periodontal Disease in Elderly

An interventional study of Baduanjin training/exercise in Chronic Periodontal Disease, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 65 Years to 75 Years. Per ClinicalTrials.gov, last updated 2022-12-23.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
65 Years to 75 Years
Sex
All
01

Study summary

The metabolic syndrome (MetS) is a spectrum of conditions that increase the risk of cardiovascular disease and diabetes mellitus. The components of MetS include dysglycemia, visceral obesity, atherogenic dyslipidemia (elevated triglycerides and low levels of high-density lipoprotein) and hypertension. An association of periodontal disease and MetS has been suggested. This association is believed to be the result of systemic oxidative stress and an exuberant inflammatory response.

Physical activity is associated as a potential tool for reduction of periodontal disease prevalence. The frequency of physical activity is directly related to a low occurrence of periodontitis.

Read the detailed description

For 6 months, MeTS elderly (25 elderly) with chronic periodontal disease will be involved in sixty-minute Baduanjin physical training (5 session weekly). Also, for 6 months, another MeTS elderly (25 elderly) with chronic periodontal disease will serve as a control non-trained group.

02

Conditions studied

  • Chronic Periodontal Disease

Browse trials for

03

In context

Chronic Periodontitis

386 studies on the registry are indexed under Chronic Periodontitis; 23 are open to participants now.

This study's planned enrollment of 50 is close to the median of 46 across 314 interventional studies indexed under Chronic Periodontitis.

Browse Chronic Periodontitis studies →

Lead sponsor

Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • fifty elderly with metabolic syndrome and chronic periodontal disease will be included
  • both sexes will be included

Exclusion criteria

Exclusion Criteria:

  • smokers
  • elderly engaged in physical activity programs
  • any cardiovascular/respiratory diseases that obstacle the conduction of Baduanjin
  • elderly on drug therapies for chronic periodontal disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Exercised group

    For 6 months, MeTS elderly (25 elderly) with chronic periodontal disease will be trained using sixty-minute Baduanjin training/exercise (5 times weekly)

    Behavioral: Baduanjin training/exercise

  • No intervention
    control group

    For 6 months, MeTS elderly (25 elderly) with chronic periodontal disease will receive no training

Interventions

  • BehavioralBaduanjin training/exercise

    For 6 months, MeTS elderly (25 elderly) with chronic periodontal disease will be trained using sixty-minute Baduanjin training/exercise (5 times weekly)

06

What researchers measure

Primary outcomes

  1. Periodontal disease index

    it will assess periodontal health status

    Time frame: It will be assessed after 6-month intervention

Secondary outcomes

  1. Simplified oral hygiene index

    it will assess oral hygiene/cleanliness status

    Time frame: It will be assessed after 6-month intervention

  2. Interleukin 1 beta

    it will be assessed in saliva

    Time frame: It will be after 6-month intervention

  3. interleukin 6

    it will be assessed in saliva

    Time frame: It will be assessed after 6-month intervention

  4. superoxide dismutase

    it will be assessed in saliva

    Time frame: It will be assessed after 6-month intervention

  5. total antioxidant status

    it will be assessed in saliva

    Time frame: It will be assessed after 6-month intervention

07

Study locations

1 of 1 sites recruiting
  • Faculty of Physical Therapy Cairo University
    Giza, Dokki, Egypt
    Recruiting
08

References and documents

Publications

  • Ali Ismail AM, El-Moatasem AM, El-Moatasem AM. Effect of baduanjin exercise on salivary inflammatory and oxidative markers in the elderly with metabolic syndrome and periodontal disease: a randomized trial. J Bodyw Mov Ther. 2025 Dec;45:536-544. doi: 10.1016/j.jbmt.2025.09.017. Epub 2025 Sep 16. PubMed 41316618 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 23, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05484479
Lead sponsor
Cairo University
Responsible party
Ali Mohamed Ali ismail (lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University, Cairo University) — Principal investigator
First posted
Aug 2, 2022
Start date
Oct 1, 2022
Primary completion
May 1, 2023 (estimated)
Completion
May 1, 2023 (estimated)
Last update
Dec 23, 2022

Study contacts

Ali Ismail, lecturer
Contact
allooka2012@gmail.com
02 01005154209
Ali Ismail, lecturer
principal investigator · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion